Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 20

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 20
---
 employee and advisory options in accordance with article 3b of the Articles) is in the best interest of the Company.

Proposal:Subject to the condition and as of the date immediately following the implementation of Proposal2, the Board of Directors proposes that the Company’s conditional capital for employee and advisory options shall be amended and that Article 3c para. 1 (Conditional Share Capital for Shareholders’ Options) shall be amended as follows:

| “Art. 3c — Bedingtes Aktienkapital für Aktionärsoptionen                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |     | Art. 3c — Conditional Share Capital for Shareholders’ Options                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Das Aktienkapital wird im Maximalbetrag von CHF [88‘146.66] durch Ausgabe von höchstens [1‘469‘111] vollständig zu liberierenden Namenaktien (Stammaktien) mit einem Nennwert von je CHF [0.06] erhöht durch Ausübung von Optionsrechten mit einer maximalen Laufzeit von 10 Jahren, welche in Verbindung mit einem öffentlichen Angebot der Gesellschaft und Kotierung von Aktien Aktionären eingeräumt werden oder anstelle von Aktien bei bestehenden Stimmrechtsgrenzen gewährt werden oder die im Zusammenhang mit oder zur Deckung von Finanzierungsverpflichtungen gewährt werden. 
 […]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |     | The Company‘s share capital shall be increased by a maximum amount of CHF [88,146.66] through the issuance of not more than [1,469,111] registered shares (common shares), with a nominal value of CHF [0.06] each by the exercise of option rights, with a term of not more than ten years, which are granted to shareholders in connection with a public offer of the Company and the listing of shares or which are granted instead of shares in case of existing voting rights limitations or which are granted in connection with or to cover financing commitments. 
 […]”                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

The details of the proposal regarding the amount of shares is provisional. The Board of Directors will determine the final details no later than the morning of the NLS Meeting and will finalize this proposal accordingly, which does not constitute an amendment to the proposal. The goal is to allow for a maximum of options to cover ongoing capital needs of the Company (i.e., additional 50